Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations

Neuroscience Letters

Volumn 260, Issue 3, 1999, Pages 193-195

  Houlden, Henry ^a   Rizzu, Patrizia ^b   Stevens, Martijn ^c   De Knijff, Peter ^d   Van Duijn, Cornelia M ^b   Van Swieten, John C ^c   Heutink, Peter ^b   Perez Tur, Jordi ^a   Thomas, Valerie ^a   Baker, Matt ^a   Morris, Huw ^e   Rossor, Martin ^e   Jannsen, John C ^e   Petersen, Ron C ^f   Dodd, Peter ^g   Dark, Frances ^h   Boeve, Brad ^f   Dickson, Dennis ^a   Davies, Peter ⁱ   Pickering Brown, Stuart ^j   Mann, David ^j   Adamson, Jennifer ^a   Lynch, Tim ^k,l   Payami, Haydeh ^k,l   Poorkaj, Parvoneh ^m   Bird, Thomas D ^m   Schellenberg, Gerald D ^m   Chakraverty, Sumi ⁿ   Norton, Joanne ⁿ   Morris, John C ⁿ   Goate, Alison ⁿ   Hutton, Mike ^a   Hardy, John ^a   more..

^a MAYO CLINIC   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f MAYO CLINIC ROCHESTER   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h PRINCESS ALEXANDRA HOSPITAL   (Australia)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^l OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ WASHINGTON UNIVERSITY   (United States)

more..

Author keywords

Alzheimer's disease; Apolipoprotein E; Frontotemporal dementia with parkinsonism linked to chromosome 17; Tau

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ARTICLE; DEMENTIA; FAMILY; GENE; GENE MUTATION; GENOTYPE; HUMAN; ONSET AGE; PRIORITY JOURNAL;

EID: 0033525134     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00931-8     Document Type: Article

References (22)

1. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17:1997;263-264.
2. Crook R., Hardy J., Duff K. Single-day apolipoprotein E genotyping. J. Neurosci. Methods. 53:1994;125-127.
3. Chartier-Harlin M.C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., Hardy J., Roberts G.W. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3:1994;569-574.
4. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
5. Farrer L.A., Abraham C.R., Volicer L., Foley E.J., Kowall N.W., McKee A.C., Wells J.M. Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp. Neurol. 136:1995;162-170.
6. Foster N.L., Wilhelmsen K., Sima A.A., Jones M.Z., D'Amato C.J., Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann. Neurol. 41:1997;706-715.
7. Gearing M., Mori H., Mirra S.S. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann. Neurol. 39:1996;395-399.
8. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
9. Hardy J., Duff K., Gwinn-Hardy K., Perez-Tur J., Hutton M. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nature Neurosci. 1:1998;355-358.
10. Houlden H., Collinge J., Kennedy A., Newman S., Rossor M., Lannfelt L., Lilius L., Winblad B., Crook R., Duff K., Hardy J. ApoE genotype and Alzheimer's disease. Lancet. 342:1993;737-738.
11. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Heutink P.et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
12. Mann D.M., Iwatsubo T., Pickering-Brown S.M., Owen F., Saido T.C., Perry R.H. Preferential deposition of amyloid beta protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci. Lett. 221:1997;81-84.
13. Nacmias B., Latorraca S., Piersanti P., Forleo P., Piacentini S., Bracco L., Amaducci L., Sorbia S. ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val→Ile mutated families. Neurosci. Lett. 183:1995;1-3.
14. Poirier J. Apolipoprotein E in the brain and its role in Alzheimer's disease. J. Psychiatry Neurosci. 21:1996;128-134.
15. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43:1998;815-825.
16. Royston M.C., Mann D., Pickering-Brown S., Owen F., Perry R., Raghavan R., Khin-Nu C., Tyrer S., Day K., Crook R., Fruchart J.-C., Delacourte A., Rossor M., Amouyel P. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. NeuroReport. 5:1994;2583-2585.
17. Spillantini M.G., Goedert M., Crowther R.A., Murrell J.R., Farlow M.R., Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc. Natl. Acad. Sci. USA. 94:1997;4113-4118.
18. Spillantini M.G., Bird T.D., Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol. 8:1998;387-402.
19. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA. 95:1998;7737-7741.
20. Stevens M., van Duijn C.M., Kamphorst W., de Knijff P., Heutink P., van Gool W.A., Scheltens P., Ravid R., Oostra B.A., Niermeijer M.F., van Swieten J.C. Familial aggregation in frontotemporal dementia. Neurology. 50:1998;1541-1545.
21. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.M., Jakes R., Alberts M.J., Gilbert J.R., Pericak-Vance J.M., Roses A.D. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:1994;163-171.
22. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.